Name: Evolving Role of Pet-Guided Interventional Oncology, an Issue of pet Clinics (Volume 14-4) (The Clinics: Radiology, Volume 14-4) (en Inglés)
Price: 86.74 USD
Availability: InStock
Author: Alavi Abass,El-Haddad Ghassan,Lam Marnix G. E. H.
ISBN: 9780323681896

portada Evolving Role of Pet-Guided Interventional Oncology, an Issue of pet Clinics (Volume 14-4) (The Clinics: Radiology, Volume 14-4) (en Inglés)

Evolving Role of Pet-Guided Interventional Oncology, an Issue of pet Clinics (Volume 14-4) (The Clinics: Radiology, Volume 14-4) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier

Autor

Alavi Abass,El-Haddad Ghassan,Lam Marnix G. E. H.

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323681896

N° edición

Evolving Role of Pet-Guided Interventional Oncology, an Issue of pet Clinics (Volume 14-4) (The Clinics: Radiology, Volume 14-4) (en Inglés)

Alavi Abass,El-Haddad Ghassan,Lam Marnix G. E. H. (Autor) · Elsevier · Tapa Dura

Libro Nuevo Importado

Envío: 23 a 30 días háb.

$ 157.71$ 86.74

-45%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 100 unidades

$ 86.74

Llega entre el 28 Ago y el 10 Sep a Quito, Pichincha. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Evolving Role of Pet-Guided Interventional Oncology, an Issue of pet Clinics (Volume 14-4) (The Clinics: Radiology, Volume 14-4) (en Inglés)"

This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!